Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,435.00
Bid: 1,454.00
Ask: 1,456.00
Change: -5.00 (-0.35%)
Spread: 2.00 (0.138%)
Open: 1,440.00
High: 1,474.00
Low: 1,435.00
Prev. Close: 1,440.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Pound Sees FTSE 100 End Lower As US Stocks Rise

Thu, 11th Jul 2019 17:05

(Alliance News) - Stocks in London ended mixed on Thursday as the strong pound hindered the FTSE 100, while US equity markets continued to prosper from the dovish comments on Wednesday from Federal Reserve Chair Jerome Powell. The FTSE 100 index closed down 20.87 points, or 0.3%, at 7,509.82. The FTSE 250 ended up 23.78 points, or 0.1%, at 19,443.16, and the AIM All-Share closed up 2.78 points, or 0.3%, at 917.51.The Cboe UK 100 ended down 0.3% at 12,737.57, the Cboe UK 250 closed up 0.2% at 17,377.83, and the Cboe Small Companies ended up 0.1% at 11,240.96.In Paris the CAC 40 ended down 0.3%, while the DAX 30 in Frankfurt ended down 0.3%. City Index analyst Fiona Cincotta said: "The pound capitalised on the weakness of both the euro and the US dollar, extending gains versus its peers. Clearly the case of 'best of a bad bunch'. Whilst the ECB and the Fed are poised to cut imminently, the BoE still has time on its side ahead of a potential no deal Brexit come October 31. Despite warnings from Carney over the damage of a no deal Brexit, the pound pushed to a high of USD1.2571."After spending the morning in positive territory, the FTSE weighed down into the red, struggling under the stronger pound."The pound was quoted at USD1.2555 at the London equities close, up from USD1.2493 at close Wednesday, shrugging off 'no deal' Brexit warnings from Bank of England Governor Mark Carney. The BoE said UK banks could withstand the worst case no-deal Brexit scenario and a full-scale global trade war but warned "material risks of economic disruption" remain from a cliff-edge EU withdrawal.In the latest report from the Financial Policy Committee, the central bank said it had assessed lenders against a doomsday no-deal Brexit scenario together with a global slowdown sparked by the US-China trade war and found they would still be able to continue lending to UK households and businesses.However, Carney cautioned that the UK would still suffer a "major economic shock" if it crashed out of the EU, adding that the threat of a no-deal had increased in recent months.However, Carney also stressed the UK financial system was "ready for Brexit whatever form it takes".In addition, Carney dodged questions surrounding his future with speculation rife he will succeed the outgoing Christine Lagarde as head of the International Monetary Fund once his term as BoE governor ends. The Canadian, who holds both British and Irish passorts, is due to end his stint at the helm of the BoE at the end of January 2020. Carney has been installed by bookmakers as an early favourite to take over at the IMF once Lagarde is confirmed as president of the Frankfurt-based European Central Bank.IG Group's Josh Mahony said: "While GBP/USD is on the rise due to the Powell-led dollar devaluation, Carney's recent shift in tone is driving up expectations of a post-Brexit rate cut. Markets are currently pricing in a 48% chance that the BoE will cut rates in January, and thus there is plenty reason to believe the pound will fall further before long. "Today's financial stability report was a positive one for UK banks, with the likes of Barclays and RBS outperforming the index amid Carney's claims that the sector is fully prepared for even the worst form of Brexit."UK banks Barclays and Royal Bank of Scotland ended up 0.9%, 0.8% respectively, but Lloyds Banking Group ended down 0.4%. On the London Stock Exchange, housebuilders ended among the best blue chip performers following the latest results from the Royal Institution of Chartered Surveyors UK Residential Market Survey.Barratt Developments closed up 5.2%, Taylor Wimpey up 1.6%, Berkeley Group up 1.4% and Persimmon up 0.9%.Appetite for buying a home has picked up for the first time in nearly three years, surveyors have reported. An overall net balance of 10% more surveyors saw an increase rather than a decrease in interest from new buyers in June, according to RICS. Moreover, here are signs of a more stable trend in the supply of homes coming on the market, RICS said. For the first time in a year, surveyors are seeing positive growth in properties being listed for sale. "Investors raced to snap up shares in housebuilders after the latest RICS survey showed some signs of recovery in the housing market. Although it is too early to call a bounce-back in the property market based on one set of data, the news does offer a glimmer of hope for investors in housebuilding stocks," AJ Bell's Russ Mould said.Reckitt Benckiser closed up 2.5% after the household goods maker said it agreed with the US Department of Justice and the Federal Trade Commission to resolve an investigation into the sales and marketing of Suboxone Film by Indivior.Indivior was demerged from Reckitt, which makes Dettol disinfectant and Strepsils lozenges, in 2014. Suboxone is an opioid used to treat opioid addiction, acute pain, and chronic pain.Reckitt said it will pay up to USD1.4 billion to fully resolve all federal investigations into Reckitt in connection with the Indivior indictment and claims relating to state Medicaid programs for those states choosing to participate in the settlement.The settlement amount will be funded through existing borrowing facilities and cash generation, Reckitt said."The settlement will be a meaningful drag on cash flow at a time when the group is looking to shift the debt taken on to fund its USD18 billion acquisition of Mead Johnson in 2017, but Reckitt's cash generative business model should mean it can still reduce that debt pile and increase the dividend in the years ahead despite the cost of this settlement," said Hargreaves Lansdown's George Salmon. Indivior closed up 6.7% after the opioid addiction treatment producer revised its expectations for 2019 net revenue and net income higher following a stronger-than-expected first half. Indivior also said its own case with the US DoJ is separate from that of its former parent company.In April, the DoJ charged the drugmaker with using a fraudulent marketing scheme to boost prescriptions of its flagship opioid addiction treatments, causing the stock to plummet. Elsewhere, insurance giant Swiss Re said it suspended plans to float its UK business ReAssure Group in London after potential investors' interest fell off because of the poorer global economic outlook and concerns about a possible no-deal Brexit.The euro stood at USD1.1260 at the European equities close, slightly higher than USD1.1248 late Wednesday.Minutes from the European Central Bank's last monetary policy meeting showed rate setters stand ready to act in light of heightened uncertainties.At the bank's June meeting, the ECB said it expects key interest rates to remain at current levels "at least through the first half of 2020".The interest rates on refinancing operations, marginal lending facility and on the deposit facility were kept at 0.00%, 0.25% and minus 0.40%, respectively. These rates have been at record lows following the 2011 eurozone debt crisis.The accounts from the meeting, released on Thursday, showed Governing Council members observed that since their last meeting in April, US trade negotiations with both China and Mexico had "progressively deteriorated", denting global equity markets. Stocks in New York were higher at the London equities close, as the Dow Jones Industrial Average crossed the 27,000 mark for the first time on hopes of an interest rate cut from the US Federal Reserve later this month. The DJIA was up 0.7%, the S&P 500 index was up 0.2% and the Nasdaq Composite was up 0.1%.In the first day of closely watched congressional testimony, Powell said the case for lower borrowing costs "had strengthened" owing to headwinds caused by global trade uncertainty.On the economic front, US inflation slowed to 1.6% compared to June 2018, two tenths of a point lower than in May and the second straight year-on-year decline. The core index is up 2.1% compared to a year ago."This report won't stop the Fed from easing on [July] 31 but it does suggest that a 50 basis point cut would be risky," said Pantheon Macroeconomics analyst Ian Shepherdson.The Fed, which has a 2.0% inflation target, tracks the core personal consumption expenditures price index as its preferred gauge for monetary policy. The core PCE price index increased 1.5% year-on-year in May and has missed its target this year.Brent oil was quoted at USD66.95 a barrel at the London equities close, up from USD66.10 at the close Wednesday. The North Sea benchmark hit an intraday high of USD67.62 in morning trade - its highest level in six weeks, as oil rigs in the Gulf of Mexico were evacuated ahead of a hurricane.Gold was quoted at USD1,412.00 an ounce at the London equities close, higher than USD1,407.00 late Wednesday.The economic events calendar on Friday has China trade data overnight, eurozone industrial production figures at 1000 BST and US producer prices at 1330 BST. The UK corporate calendar on Friday has trading statements from emerging markets-focused asset manager Ashmore Group and no-frills gymnasiums operator Gym Group. London Close is available to subscribers as an email newsletter. Contact info@alliancenews.com

More News
28 Jul 2023 09:46

LONDON BROKER RATINGS: KBW cuts Aviva 'market perform'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
27 Jul 2023 11:48

Indivior raises 2023 guidance after strong half-year progress

(Alliance News) - Indivior PLC on Thursday celebrated a strong recent six months and second quarter that brough increased profit and revenue, boosting its optimism for the rest of the year.

Read more
27 Jul 2023 10:04

Indivior lifts guidance after strong first half

(Sharecast News) - Pharmaceuticals firm Indivior reported a 24% improvement in net revenue in its half-year report on Thursday, to $529m.

Read more
12 Jun 2023 07:53

LONDON BRIEFING: Shares on the rise; Frasers buys into AO World

(Alliance News) - Stocks in London were set to open higher on Monday, at the start of a busy week of central bank moves.

Read more
5 Jun 2023 07:46

Indivior reaches settlement in litigation with US states

(Sharecast News) - Addiction treatment-focussed pharmaceuticals company Indivior announced on Monday that its subsidiary Indivior Inc has successfully reached an agreement to resolve the claims brought against it by the attorneys general of 41 US states and the District of Columbia.

Read more
2 Jun 2023 18:18

Indivior settles antitrust claims in US regarding Suboxone drug

(Alliance News) - Indivior PLC on Friday said it has reached an agreement to resolve the claims brought in antitrust multi-district litigation regarding its drug Suboxone.

Read more
25 May 2023 09:23

LONDON BROKER RATINGS: Numis starts Tristel with 'add'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
23 May 2023 09:56

Indivior emergency opioid overdose treatment approved by US FDA

(Alliance News) - Indivior PLC on Tuesday said the US Food & Drug Administration has approved its OPVEE nasal spray for the emergency treatment of opioid overdose.

Read more
23 May 2023 07:48

Indivior's opioid addiction sprat approved by FDA

(Sharecast News) - US health regulators have approved Indivior's Opvee nasal spray treatment for opiod addiction, the company said on Tuesday.

Read more
10 May 2023 17:02

DIRECTOR DEALINGS: Indivior division chief sells GBP1.7 million shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and not separately reported by Alliance News:

Read more
27 Apr 2023 15:49

UK shareholder meetings calendar - next 7 days

Friday 28 April 
AQRU PLCAGM
Audioboom Group PLCAGM
BBGI Global Infrastructure SAAGM
Everest Global PLCAGM
GetBusy PLCAGM
Greencoat Renewables PLCAGM
Greencoat UK Wind PLCAGM
Hikma Pharmaceuticals PLCAGM
JPMorgan Claverhouse Investment Trust PLCAGM
Kingspan Group PLCAGM
ME Group International PLCAGM
Minoan Group PLCAGM
Pearson PLCAGM
Rotork PLCAGM
Shanta Gold LtdAGM
Smurfit Kappa Group PLCAGM
Symphony International Holdings LtdAGM
Monday 1 May 
no events scheduled 
Tuesday 2 May 
Carr's Group PLCGM re annual report and directors remuneration report
CVC Income & Growth LtdAGM
IOG PLCAGM
Ocado Group PLCAGM
Plus500 LtdAGM
Wednesday 3 May 
Apax Global Alpha LtdAGM
Barclays PLCAGM
GSK PLCAGM
Hyve Group PLCCourt Meeting & GM re acquisition by Heron UK Bidco Ltd
Logistics Development Group PLCAGM
Okyo Pharma LtdGM re proposed cancellation of the ordinary shares of no par value
Reach PLCAGM
Reckitt Benckiser Group PLCAGM
Standard Chartered PLCAGM
Tritax Big Box REIT PLCAGM
Unilever PLCAGM
Thursday 4 May 
AIB Group PLCAGM
Aviva PLCAGM
Aviva PLCGM re capital reduction
BAE Systems PLCAGM
Bivictrix Therapeutics PLCAGM
Domino's Pizza Group PLCAGM
Glanbia PLCAGM
Grafton Group PLCAGM
Hammerson PLCAGM
Howden Joinery Group PLCAGM
Hurricane Energy PLCCourt Meeting & GM re takeover by Prax Exploration & Production PLC  
Indivior PLCAGM
IMI PLCAGM
Irish Residential Properties REIT PLCAGM
ITV PLCAGM
Jardine Matheson Holdings LtdAGM
Johnson Service Group PLCAGM
LungLife AI IncAGM
Mincon Group PLCAGM
Mondi PLCAGM
Moneysupermarket.com Group PLCAGM
Morgan Sindall Group PLCAGM
Spirent Communications PLCAGM
Personal Group Holdings PLCAGM
Phoenix Group Holdings PLCAGM
Rathbones Group PLCAGM
SIG PLCAGM
Ten Entertainment Group PLCAGM
Travis Perkins PLCAGM
Witan Investment Trust PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
27 Apr 2023 14:41

Indivior lifts revenue guidance, cuts profit outlook after Opiant deal

(Sharecast News) - Opioid addiction treatment maker Indivior lifted its full-year revenue guidance on Thursday but trimmed its outlook for operating profit due to costs related to the acquisition of Opiant Pharmaceuticals, as it posted a jump in first-quarter profit and revenue.

Read more
27 Apr 2023 13:46

Indivior raises 2023 revenue forecast following Opiant acquisition

(Alliance News) - Indivior PLC on Thursday said net revenue increased by more than 20% in the first quarter, lifting profit, and it updated its guidance for the year following its acquisition of Opiant Pharmaceuticals Inc last month.

Read more
20 Apr 2023 15:41

UK earnings, trading statements calendar - next 7 days

Friday 21 April 
Angle PLCFull Year Results
BHP Group LtdTrading Statement
Lookers PLCFull Year Results
Monday 24 April 
Brighton Pier Group PLCFull Year Results
CentralNic Group PLCTrading Statement
Checkit PLCFull Year Results
Egdon Resources PLCHalf Year Results
Keystone Law Group PLCFull Year Results
Lok'n Store Group PLCHalf Year Results
Novacyt SAFull Year Results
Tuesday 25 April 
AB Dynamics PLCHalf Year Results
Anglo American PLCTrading Statement
Associated British Foods PLCHalf Year Results
Avacta Group PLCFull Year Results
Banco Santander SAQ1 Results
Card Factory PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Corero Network Security PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
hVIVO PLCFull Year Results
IWG PLCTrading Statement
Jadestone Energy PLCFull Year Results
Next Fifteen Communications Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Oxford BioMedica PLCFull Year Results
Petrofac LtdFull Year Results
Quilter PLCTrading Statement
Resolute Mining LtdTrading Statement
RWS Holdings PLCTrading Statement
Travis Perkins PLCTrading Statement
WAG Payment Solutions PLCTrading Statement
Whitbread PLCFull Year Results
Wednesday 26 April 
1Spatial PLCFull Year Results
Biome Technologies PLCFull Year Results
Bunzl PLCQ1 Results
C4X Discovery Holdings PLCHalf Year Results
CRH PLCTrading Statement
Ecora Resources PLCTrading Statement
Frenkel Topping Group PLCFull Year Results
Fresnillo PLCTrading Statement
Gem Diamonds LtdTrading Statement
Glencore PLCTrading Statement
GSK PLCQ1 Results
Home REIT PLCHalf Year Results
Learning Technologies Group PLCFull Year Results
Man Group PLCTrading Statement
Pennant International Group PLCFull Year Results
RBG Holdings PLCFull Year Results
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Skillcast Group PLCFull Year Results
Smith & Nephew PLCTrading Statement
Standard Chartered PLCQ1 Results
Trifast PLCTrading Statement
Warpaint London PLCFull Year Results
Thursday 27 April 
AstraZeneca PLCTrading Statement
Barclays PLCQ1 Results
Brave Bison Group PLCFull Year Results
Capricorn Energy PLCFull Year Results
GCP Infrastructure Investments LtdTrading Statement
Howden Joinery Group PLCTrading Statement
Inchcape PLCTrading Statement
Indivior PLCQ1 Results
Inspecs Group PLCFull Year Results
J Sainsbury PLCFull Year Results
Lancashire Holdings LtdTrading Statement
Literacy Capital PLCTrading Statement
London Stock Exchange Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Schroders PLCTrading Statement
Spectris PLCQ1 Results
St James's Place PLCTrading Statement
Synairgen PLCFull Year Results
Taylor Wimpey PLCTrading Statement
Unilever PLCTrading Statement
WPP PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
2 Mar 2023 17:47

IN BRIEF: Indivior completes acquisition of Opiant Pharmaceuticals

Indivior PLC - North Chesterfield, Virginia-based pharmaceutical company - Completes the acquisition of Opiant Pharmaceuticals Inc. Says the acquisition will strengthen its addiction treatment and science portfolio through the addition of Opiant's late-stage assets, notably OPNT003, an investigational opioid overdose treatment.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.